Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BASi, Pinnacle Collaborate on Glucose Monitoring | Contract Pharma
Breaking News, Collaborations & Alliances

BASi, Pinnacle Collaborate on Glucose Monitoring

Will combine methods for diabetes data collection

BASi has entered a collaboration with Pinnacle Technology for proof-of-concept studies combining BASi’s Culex NxT automated blood sampling system with Pinnacle’s glucose sensor to create a new option for quality data collection for diabetes and other glucose research.
 
“Our approach has two important advantages over traditional methods: automation of blood sampling made possible by our Culex NxT, and accurate monitoring of glucose levels using the Pinnacle glucose sensor with no net removal of blood from the test subjects. This allows researchers to take many glucose readings with no ill effects on the test subjects, resulting in more accurate glucose readings than are possible with manual sampling. The system also enables researchers to conduct pharmacokinetic, metabolism, telemetry or microdialysis studies from one set of test subjects instead of using three or four sets, thus lowering study costs,” said Jacqueline M. Lemke, president and chief executive officer and chief financial officer of BASi.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters